OPHTHALMOLOGY PACS MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America continues to dominate the ophthalmology PACS market. The region is expected to account for 40.2 % of the market share in 2024. With a strong healthcare infrastructure and high healthcare expenditure, the U.S. accounts for the majority of the regional market share. Key players in this region have established robust supply chains and distribution networks to cater to the large patient population base effectively. In addition, favorable government policies supporting the digitization of health records are boosting the adoption of PACS solutions across eye care facilities. With the goal of improving diagnostic accuracy and clinical workflow efficiency, leading hospitals and retinal clinics in the U.S. have upgraded their imaging systems with advanced PACS offerings.

Asia Pacific is poised to witness the fastest growth in the ophthalmology PACS market over the forecast period. Rapidly developing economies such as China and India are experiencing increased investment from both public and private sectors to modernize their eye care sector. This has created lucrative opportunities for PACS vendors to penetrate these untapped markets. Moreover, growing medical tourism as well as rising incidence of eye disorders due to aging population are fueling demand. Local manufacturers are also entering strategic collaborations with global PACS giants to strengthen their presence. Favorable government initiatives promoting digital health are further supporting the regional market expansion.